WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 2'4201 Infant (under 12 months) mortality rate: 422
GDP / capita (US$): 6'6991 Child (under 5 years) mortality rate: 542

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 742  729  717  705  692  564  536  413 
Births 15  15  15  15  15  16  20  18 
Surviving infants 14  14  14  14  14  15  18  16 
Pop. less than 5 years 71  70  70  70  70  75  90  73 
Pop. less than 15 years 212  213  213  215  217  229  233  176 
Female 15-49 years 195  191  186  181  176  132  116  91 

Number of reported case

(Click for retrospective incidence data for Bhutan)
Diphtheria
Japanese encephalitis 27 
Measles 10  21  418  173  1'642 
Mumps 198  262  218  1'967 
Pertussis 18  464 
Polio*
Rubella 15 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 23 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bhutan)
Vaccine year result method % card seen                                                
BCG 2007  100  EPI   98.0  95  95  95  96  99  97  87  43 
DTP1 2007  100  EPI   98.0  97  93  94  96  97  99 
DTP3 2007  100  EPI   98.0  97  95  95  96  96  92  84 
HepB_BD          60  29 
HepB3 2007  100  EPI   98.0  97  95  95  96  96  98 
Hib3          97 
JapEnc         
MCV 2007  99  EPI   98.0  95  95  95  98  99  79  21 
MCV2          90  95  85  90  72 
PCV1         
PCV3         
Pol3 2007  100  EPI   98.0  97  95  95  96  96  98  84 
Rota1         
Rota_last         
Rubella1          95  95  98  99 
TT2plus 2007  97  EPI   98.0  79  80  80  80  82  76  63 
PAB         
VAD1          44  90 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bhutan)
BCG 95  95  96  94  99  97  99  43 
DTP1 97  98  94  97  97  96  98  25 
DTP3 97  95  91  93  96  92  96 
HepB3 97  95  91  93  96  98 
Hib3 97 
MCV 95  95  95  94  99  78  93  21 
PAB 89  89  89  89  89  85  63 
PCV3
Pol3 97  95  92  93  96  98  96 
Rota_last

Number of districts in the country 20  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 80
From 80 to 89% 15
From 50 to 79% 5
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 24 months; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 12 years; +2, +6 momths; Yes 12 to 18 years girls
HepB Birth;
MR 9, 24 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Td 6, 12 years; 1st contact pregnancy; +1 month; 1 dose for subsequent pregnancies
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2'013  2'013  2009-2013  2009-2013  2009-2013  2009-2013  Jun 2008 to Jun 2013 
Nº of districts with microplans that include activities to raise immunization coverage number 20  20  20  20       

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 20  20  20  20  20  20  20 
Nº districts with DTP3 coverage >=80% number 19  19  18  17  19  18  20 
% of districts with DTP3 coverage >=80% From 0 to 100% 95  95  90  85  95  90  100 
Nº districts with measles (MCV1) coverage >=95% number 13  14  15     
% of districts with MCV1 coverage >=95% From 0 to 100% 40  40  65  70  75     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 14     

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.